Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (6696)	1/14/1999 12:33:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

January 13, 1999 Drug Stocks May Not Be Seen As Haven In Troubled Mkt By Raymond Hennessey NEW YORK (Dow Jones)--Large-capitalization drug stocks might not be the haven amid this newest market downturn that they have been in past times of market volatility, analysts said. Traditionally, during market downturns, investors pour money into big-name pharmaceutical companies like Pfizer Inc. (PFE) and Merck & Co. (MRK) because of their predictable earnings stream and isolation from emerging markets. But investors may not be so quick to turn to the drug companies from the downturn brought on Wednesday by the resignation of Gustavo Franco, Brazil's central bank chief, and the widening of the band in which the Brazilian real trades against the dollar. For one thing, the drug companies have been victims of their own success, with valuations much higher than they have been in the past, said Hemant Shah, an analyst with HKS & Co. "They may decline a little less than the broader market, but they're clearly not the safe haven they would have been if their valuations were not so high," Shah said. At the end of 1998, the major drug companies were trading at about 34 times their 1999 earnings estimates, while the S&P 500 averaged 25.9 times forward earnings, said Neil Sweig, an analyst with Southeast Research Partners. There has been some profit-taking in the beginning of 1999, Sweig said, and that could continue through the rest of this month as the stocks suffer from their own "January effect." Portfolio managers generally sell their drug stocks after the first of the year to take profits and evaluate some of the trends in the industry before returning to the stocks, Sweig said. What further hurts the stocks is the source of the latest economic worries: Brazil. "Brazil is very important to many U.S.-based companies, including the drug companies," Sweig said. Drug stocks were mixed Wednesday. Pfizer was up 1 3/4 or 1.5%, to 115 7/16. Eli Lilly & Co. (LLY) traded up 3 3/4, or 4.9%, to 80 1/4. Warner-Lambert Co. (WLA) edged 1/8, 0.2%, higher to 69 7/8. Pharmacia & Upjohn Inc. (PNU) were up 1 5/16, or 2.5%, to 54 1/4. Trading down were Merck, off 13/16, or 0.5%, to 147 1/8, and Bristol-Myers Squibb Co. (BMY), off 1 5/8, or 1.3%, to 127. Johnson & Johnson (JNJ) was also down, shedding 1 1/16, or 1.3%, to 78 3/4, while Glaxo Wellcome PLC's (GLX) ADRs were off 1/2 or 0.7%, to 70 1/4.

To: BigKNY3 who wrote (6696)	1/14/1999 12:39:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

1999 Pharma Portfolio Challenge 1/12/99 A record 57 pharmers have entered this year's Portfolio Challenge representing over 50 different portfolios. Please review your entries for accuracy. If your entry is missing, please repost. Thanks for entering Da Challenge! Please note that any entrant who posts personal attacks on the PFEr Boards during the year will be deemed ineligible and the entry will be removed. Have PFun! BigKNY3 J-E-T-S...Jets, Jets, Jets mikesports.com submitted by Prvateplez . #1 % of Pharmer Holding Total Other Holdings 1 A1raraavis PFE 60% 30%: MRK, 10%: AMGN 2 Ael002 PFE 75% 25%:BMY 3 AKASONNY PFE 100% 4 Alpine26 PFE 25% 25%:AHP/SBH/JNJ 5 ATCBN PFE 60% 40%:SGP 6 Bagassosis AHP/GLX 25% 25%: PFE/MRK 7 BEN INC11 PFE 100% 8 BigKNY3 PFE 60% 20%:MRK, 10%:GLX/WLA 9 blowbill PFE 40% 30%: SGP/WLA 10 Cash Cash 100% 11 Celtic422 PFE 50% 25%: SGP/MRK 12 Chewiepop AMGN 25% 15%:PFE/LLY/JNJ,10%: WLA/ABT 13 ChunkyD1 PFE 100% 14 Cisco 320 PFE 100% 15 DBrown1041 PFE 40% 30%: BMY/MRK 16 Doctor Di PFE 55% 33%: WLA, 12% MRK 17 DRUG STOCK PNU 100% 18 FOOLW2B PFE 50% 50%: SGP 19 Gamblerd PFE 40% 30%: SGP/WLA 20 GaryD711 ABT 40% 35%:PFE, 25%:JNJ 21 GDJNS PFE/MRK 50% 22 Gman332 SBH 60% 30%:AHP, 10% PNU 23 Haod3 PFE/MRK 40% 20%:WLA 24 IURAVEN PFE/LLY 50% 25 James Baker* PFE/LLY 30% 20%: MRK/WLA 26 JHSudduth PFE 100% 27 Jlke100905 SGP 34% 33%: PFE/WLA 28 JWasiko215 PFE 50% 25%:PNU/BMY 29 Kathya3333 MRK 75% 25%: PFE 30 L33England PFE 60% 20%: AMGN/WLA 31 LostBoy337 PFE/WLA 40% 20%:AHP 32 LSarmie26 PFE 40% 30%:WLA,20%:AMGN,10%:SGP 33 LUNATICFRN PFE 50% 25%:AHP/MRK 34 Malterpoint PFE 66% 14%:MRK,10%:LLY/JNJ 35 MB* PFE/SGP 50% 36 MBTAY PFE 75% 25%:AMGN 37 McMenus PFE 40% 25%: AMGN/MRK, 10%:JNJ 38 Melizrod PFE 40% 35%: MRK, 25%:AMGN 39 MERCK GAL AHP 99% 1%: MRK 40 Nat Nithi* PFE 50% 30%:SGP, 20%: LLY 41 Neloe PFE 50% 30%:SGP, 20%:WLA 42 Nogriefplz PFE 80% 20%: ABT 43 Northon PFE 50% 25%:GLX/ MRK 44 Phulish123 AHP 40% 30%:MRK/WLA 45 PRESSmUP SGP 40% 30%:PFE/AMGN 46 Pridman PFE 35% 30%:WLA,20%:MRK,15%:BMY 47 Prvateplez PFE 60% 40%:MRK 48 PUNKIN611 WLA 40% 30%:PFE, 15%:LLY/SGP 49 Rapidtest PFE 40% 20%: AHP/MRK, 10% SBH, 10%S WLA 50 RCasper568 PFE 50% 25%: SGP/WLA 51 RexLuv AMGN 40% 20%: LLY/PFE/WLA 52 Robo11445 PFE 50% 30%:WLA, 20%:SGP 53 ROGPOW BMY 40% 20%: JNJ/PFE,10%: LLY/MRK 54 Ron FlanaganPFE/MRK/AMGN 33% 1%: Cash 55 RPH75 PFE/WLA 30% 20%:SGP,10%:PNU/LLY 56 Sinbadnaz MRK 50% 25%: PFE/AMGN 57 Uclaborn PFE 50% 40%: SGP. 10%:WLA 58 VandanaJ PFE 50% 20%: MRK/WLA Submitted via the Silicon Investor PFE Board